Insufficient scRNA-seq data for expression of PIP5KL1 at single-cell level.
Insufficient scRNA-seq data for expression of PIP5KL1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 96% | 99.60 | 173 / 180 | 98% | 4.03 | 421 / 430 |
lung | 99% | 207.09 | 575 / 578 | 85% | 5.76 | 987 / 1155 |
uterus | 100% | 165.75 | 170 / 170 | 81% | 3.25 | 374 / 459 |
thymus | 99% | 178.18 | 645 / 653 | 81% | 4.68 | 492 / 605 |
breast | 96% | 179.71 | 439 / 459 | 78% | 2.99 | 874 / 1118 |
brain | 92% | 149.02 | 2431 / 2642 | 73% | 1.61 | 513 / 705 |
esophagus | 100% | 169.91 | 1440 / 1445 | 65% | 1.85 | 119 / 183 |
bladder | 100% | 110.29 | 21 / 21 | 59% | 2.33 | 297 / 504 |
pancreas | 88% | 71.16 | 289 / 328 | 62% | 1.57 | 110 / 178 |
prostate | 100% | 304.45 | 245 / 245 | 41% | 0.78 | 208 / 502 |
skin | 100% | 264.32 | 1808 / 1809 | 28% | 0.63 | 133 / 472 |
stomach | 99% | 126.58 | 355 / 359 | 22% | 0.44 | 64 / 286 |
intestine | 91% | 90.26 | 880 / 966 | 25% | 0.57 | 132 / 527 |
kidney | 100% | 113.52 | 89 / 89 | 16% | 0.38 | 142 / 901 |
adrenal gland | 41% | 23.57 | 106 / 258 | 60% | 2.19 | 138 / 230 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.13 | 1 / 1 |
blood vessel | 99% | 119.10 | 1326 / 1335 | 0% | 0 | 0 / 0 |
spleen | 95% | 74.79 | 230 / 241 | 0% | 0 | 0 / 0 |
adipose | 95% | 81.13 | 1138 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 89% | 3.26 | 40 / 45 |
lymph node | 0% | 0 | 0 / 0 | 55% | 0.87 | 16 / 29 |
peripheral blood | 35% | 18.64 | 327 / 929 | 0% | 0 | 0 / 0 |
liver | 12% | 5.49 | 27 / 226 | 12% | 0.31 | 47 / 406 |
heart | 17% | 9.13 | 149 / 861 | 0% | 0 | 0 / 0 |
muscle | 5% | 3.04 | 44 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 3% | 0.03 | 2 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030336 | Biological process | negative regulation of cell migration |
GO_0001933 | Biological process | negative regulation of protein phosphorylation |
GO_0046854 | Biological process | phosphatidylinositol phosphate biosynthetic process |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0010917 | Biological process | negative regulation of mitochondrial membrane potential |
GO_0042995 | Cellular component | cell projection |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0016308 | Molecular function | 1-phosphatidylinositol-4-phosphate 5-kinase activity |
GO_0005524 | Molecular function | ATP binding |
Gene name | PIP5KL1 |
Protein name | Phosphatidylinositol 4-phosphate 5-kinase-like protein 1 (PI(4)P 5-kinase-like protein 1) (PtdIns(4)P-5-kinase-like protein 1) (EC 2.7.1.68) |
Synonyms | |
Description | FUNCTION: May act as a scaffold to localize and regulate type I PI(4)P 5-kinases to specific compartments within the cell, where they generate PI(4,5)P2 for actin nucleation, signaling and scaffold protein recruitment and conversion to PI(3,4,5)P3. . |
Accessions | ENST00000300432.3 [Q5T9C9-2] Q5T9C9 ENST00000388747.9 [Q5T9C9-1] |